Larkai Healthcare's Secures $500k Investment by FAAD Network
Larkai Healthcare Pvt. Ltd., a global Med-Tech company, has successfully secured $500,000 in seed funding, a significant milestone for the company's goal of offering advanced, cost-effective, and readily available healthcare solutions powered by cutting-edge AI technology. The FAAD Network, a prominent investor network, investing in the early stages of Larkai Healthcare appears to be crucially supporting its growth. The seed funding round witnessed contributions from key investors, including FAAD Network, QI Ventures, RTAF, and additional government grants. With this financial boost, Larkai Healthcare intends to lead the way in the next wave of technological advancements in healthcare, bolstering its sales divisions through strategic investments. The funding is instrumental in expediting the company's mission to transform healthcare accessibility and efficiency on a global scale.
Dr. Dinesh Singh, Co-Founder and Director of FAAD Network, affirmed their commitment to revolutionary technological innovation, remarking, “Our investment in Larkai showcases our steadfast commitment to leading the way in transformative tech innovation. Their pioneering use of AI to revolutionize healthcare strongly aligns with our mission to drive impactful change in the technology ventures landscape”.
Established in 2020 by Mr. Pritam Dhalla and Mr. Abhilash Chakraverty, Larkai Healthcare aims to narrow the gap between diagnosis and treatment by offering rapid and accurate diagnosis through its advanced AI technology. The company's vision centers around implementing AI in healthcare, ensuring its accessibility to everyone, anywhere, and at any time. Abhilash Chakraverty, Co-Founder and Director of Larkai Healthcare, expressed enthusiasm about the investment, stating, “With this investment, we're positioned to bridge the gap between diagnosis and treatment, leveraging our global presence and robust intellectual assets. This fuels our healthcare vision—transcending geographical boundaries, transforming lives, and establishing new benchmarks in accessibility and innovation”.
Dr. Dinesh Singh, Co-Founder and Director of FAAD Network, affirmed their commitment to revolutionary technological innovation, remarking, “Our investment in Larkai showcases our steadfast commitment to leading the way in transformative tech innovation. Their pioneering use of AI to revolutionize healthcare strongly aligns with our mission to drive impactful change in the technology ventures landscape”.
Established in 2020 by Mr. Pritam Dhalla and Mr. Abhilash Chakraverty, Larkai Healthcare aims to narrow the gap between diagnosis and treatment by offering rapid and accurate diagnosis through its advanced AI technology. The company's vision centers around implementing AI in healthcare, ensuring its accessibility to everyone, anywhere, and at any time. Abhilash Chakraverty, Co-Founder and Director of Larkai Healthcare, expressed enthusiasm about the investment, stating, “With this investment, we're positioned to bridge the gap between diagnosis and treatment, leveraging our global presence and robust intellectual assets. This fuels our healthcare vision—transcending geographical boundaries, transforming lives, and establishing new benchmarks in accessibility and innovation”.